BEE-L Archives

Informed Discussion of Beekeeping Issues and Bee Biology

BEE-L@COMMUNITY.LSOFT.COM
Options: Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Content-Type:
text/plain; charset="UTF-8"
Date:
Sat, 28 Sep 2019 09:19:24 -0400
Reply-To:
Informed Discussion of Beekeeping Issues and Bee Biology <[log in to unmask]>
Subject:
Re: Fumagillin / Dicer gene therapy
Content-Transfer-Encoding:
quoted-printable
Message-ID:
<[log in to unmask]>
Sender:
Informed Discussion of Beekeeping Issues and Bee Biology <[log in to unmask]>
From:
Pete B <[log in to unmask]>
Parts/Attachments:
text/plain (11 lines) 
Just a reminder:

> Recent studies show that this antibiotic may be ineffective against N. ceranae infections (38–43). There is also evidence that fumagillin is fairly toxic and causes chromosomal aberrations, carcinogenicity in humans, and alterations to the ultrastructure of hypopharyngeal glands in bees (37). Consequentially, many countries outside of the Americas (including the European Union) have banned fumagillin for agricultural use 

Burnham, A. J. (2019). Scientific advances in controlling Nosema ceranae (Microsporidia) infections in honey bees (Apis mellifera). Frontiers in Veterinary Science, 6.

             ***********************************************
The BEE-L mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software.  For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2